Temporal Trends in Dietary Sodium Intake Among Adults Aged ≥19 Years — United States, 2003–2016

Hypertension, which can be brought on by excess sodium intake, affects nearly one half of U.S. adults and is a major risk factor for heart disease, the leading cause of death in the United States (1). In 2019, the National Academies of Sciences, Engineering, and Medicine (NASEM) established the Chronic Disease Risk Reduction (CDRR) intake, a chronic-disease–specific recommendation for dietary sodium of 2,300 mg/day. Reducing daily sodium to CDRR intake is expected to reduce chronic disease risk among healthy persons, primarily by lowering blood pressure (2). Although the 2019 sodium CDRR intake is equivalent in number to the 2005 Tolerable Upper Limit (UL) released by NASEM (then known as the Institute of Medicine), the UL was intended to provide guidance on safe intake levels, not to serve as an intake goal (2). To describe excess sodium intake in the context of the CDRR intake goal, this report analyzed National Health and Nutrition Examination Survey (NHANES) data from 2003 to 2016 to yield temporal trends in usual sodium intake >2,300 mg/day and in mean sodium intake, unadjusted and adjusted for total energy intake, among U.S. adults aged ≥19 years. The percentage of U.S. adults with sodium intake above CDRR intake was 87.0% during 2003–2004 and 86.7% during 2015–2016. Among U.S. adults overall, no significant linear trend was noted from 2003 to 2016 in unadjusted or energy intake–adjusted mean sodium intake. Small, significant declines were observed in mean usual sodium intake among some groups (adults aged 19–50 years, non-Hispanic White adults, adults experiencing obesity, and adults without hypertension). However, after energy adjustment, only adults aged ≥71 years and Mexican American adults demonstrated significant change in usual sodium intake. Many U.S. adults might be at risk for chronic disease associated with sodium intake above CDRR intake, and efforts to lower sodium intake could improve population cardiovascular health. The results of this report support enhanced efforts to reduce population sodium intake and cardiovascular disease risk, including the Food and Drug Administration’s (FDA’s) recently released guidance for the reduction of sodium in the commercially processed, packaged, and prepared food supply.*

NHANES, a series of cross-sectional surveys of nationally representative samples of the noninstitutionalized U.S. civilian population, uses a documented multistage design methodology^† to release data in 2-year cycles. This investigation used data collected from U.S. adults aged ≥19 years with valid dietary data, as determined by National Center for Health Statistics criteria,^§ during seven NHANES cycles from 2003–2004 to 2015–2016. Among 70,059 persons examined during 2003–2016, 40,544 were aged ≥19 years. Among those, 4,312 (11%) participants with incomplete or missing dietary recall data were excluded, yielding an analytic sample of 36,232. Unweighted response rates among adults aged ≥20 years examined during that period range from 53.8% (2015–2016) to 70.9% (2009–2010).^¶

Findings were stratified by sex, age group (19–30, 31–50, 51–70, and ≥71 years), race and ethnicity (non-Hispanic White, non-Hispanic Black, and Mexican American), obesity status (has or does not have obesity, defined by body mass index),** and hypertension status (has or does not have hypertension, defined by 2017 hypertension guidelines).^†† Race- and ethnicity-specific results are reported for Mexican American persons as opposed to all Hispanic persons because of consistent oversampling among Mexican American persons over time.^§§

Details on sodium intake assessment using NHANES have been published elsewhere (3–5). To estimate mean usual sodium intake, unadjusted and adjusted for energy intake and excess sodium intake (i.e., >2,300 mg/day) (2), this report used the National Cancer Institute method^¶¶ for usual intake estimation along with post-stratified adjusted balanced repeated replication weights. Up to two complete and reliable 24-hour dietary recalls*** were used for estimation of the percentage of persons above or below the intake threshold. Energy intake–adjusted sodium intake (i.e., sodium intake adjusted for total calories consumed) was estimated using the residual method (6,7) and was calculated as the sum of the expected intake for a participant with mean energy intake and the residual from the linear regression model.

To assess the statistical significance of temporal trends in sodium consumption above CDRR intake and in mean usual sodium intake, this report treated survey cycle as a continuous variable in linear regression models. The inverse value of the estimated variance from post-stratified weights was used to account for the complex survey design. All statistical analyses were performed using SAS-callable SUDAAN (version 11.0.3; RTI International), and p-values <0.05 were considered statistically significant. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.^†††

During 2003–2016, the percentage of U.S. adults aged ≥19 years whose sodium intake exceeded 2,300 mg/day ranged from 86.7% (2015–2016) to 89.2% (2011–2012) (Table 1). No significant linear trends were found among the overall population or any subgroups. Mean usual sodium intake, unadjusted for energy intake, was 3,521 mg/day during 2003–2004 and 3,468 mg/day during 2015–2016, the 2-year cycle with the lowest intake (Table 2). Temporal declines in mean usual sodium intake (average decline per 2-year cycle) were statistically significant among adults aged 19–30 years (30 mg), 31–50 years (45 mg), non-Hispanic White adults (33 mg), adults experiencing obesity (36 mg), and adults not experiencing hypertension (29 mg). Mean usual energy intake–adjusted sodium intake among U.S. adults aged ≥19 years was lowest (3,333 mg/day) during 2003–2004, and was 3,464 mg/day during 2015–2016 (Table 3). This intake decreased significantly by an average of 33 mg during every 2-year survey cycle among adults aged ≥71 years (p<0.01) and increased significantly by an average of 60 mg per survey cycle among Mexican American adults (p<0.01).

Corresponding author: Lasha S. Clarke, [email protected], 770-488-6657.

¹Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC; ²IHRC, Inc., Atlanta, Georgia; ³Panum Group LLC, Bethesda, Maryland.

References

1. CDC. Hypertension cascade: hypertension prevalence, treatment and control estimates among US adults aged 18 years and older applying the criteria from the American college of cardiology and American Heart Association’s 2017 hypertension guideline—NHANES 2013–2016. Atlanta, GA: US Department of Health and Human Services; 2019.
2. National Academies of Sciences Engineering and Medicine. Dietary reference intakes for sodium and potassium. Washington, DC: The National Academies Press; 2019.
3. Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr 2012;96:647–57. https://doi.org/10.3945/ajcn.112.034413 PMID:22854410
4. CDC. Trends in the prevalence of excess dietary sodium intake—United States, 2003–2010. MMWR Morb Mortal Wkly Rep 2013;62:1021–5. PMID:24352065
5. Sebastian RS, Wilkinson Enns C, Steinfeldt LC, Goldman JD, Moshfegh AJ. Monitoring sodium intake of the US population: impact and implications of a change in what we eat in America, National Health and Nutrition Examination Survey dietary data processing. J Acad Nutr Diet 2013;113:942–9. https://doi.org/10.1016/j.jand.2013.02.009 PMID:23567248
6. Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary intake among US adults, 1999–2012. JAMA 2016;315:2542–53. https://doi.org/10.1001/jama.2016.7491 PMID:27327801
7. Jackson SL, King SM, Zhao L, Cogswell ME. Prevalence of excess sodium intake in the United States—NHANES, 2009–2012. MMWR Morb Mortal Wkly Rep 2016;64:1393–7. https://doi.org/10.15585/mmwr.mm6452a1 PMID:26741238
8. Willett W. Nutritional epidemiology. 3rd ed. New York, NY: Oxford University Press; 2013.
9. Ford ES, Dietz WH. Trends in energy intake among adults in the United States: findings from NHANES. Am J Clin Nutr 2013;97:848–53. https://doi.org/10.3945/ajcn.112.052662 PMID:23426032
10. Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital signs: prevalence of key cardiovascular disease risk factors for million hearts 2022—United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–91. https://doi.org/10.15585/mmwr.mm6735a4 PMID:30188885

Abbreviations: BMI = body mass index; NH = non-Hispanic; SE = standard error.
* Based on the F-value; post-stratified balanced repeated replication weights were used to account for the complex survey design.
^† Persons of other or multiple races not reported; percentages will not sum to 100.
^§ Obesity status is categorized based on clinical guidelines (https://www.cdc.gov/obesity/adult/defining.html) for categorizing BMI (kg/m²), such that “Not having obesity” corresponds with a BMI <30, and “Having obesity” corresponds with a BMI ≥30.
^¶ Hypertension status is based on mean blood pressure and self-reported use of antihypertensive medications and is defined using the 2017 Hypertension Guidelines (https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf), where “Having hypertension” is defined as mean systolic blood pressure ≥130 mmHg, mean diastolic blood pressure ≥80 mmHg, or self-reported use of antihypertensive medication. For the purpose of this analysis, participants who did not meet the 2017 Hypertension Guidelines definition for hypertension were defined as “Not having hypertension.”

Abbreviations: BMI = body mass index; NH = non-Hispanic; SE = standard error.
* Based on the F-value; post-stratified balanced repeated replication weights were used to account for the complex survey design.
^† Persons of other or multiple races not reported; percentages will not sum to 100.
^§ P-value = 0.048.
^¶ Obesity status is categorized based on clinical guidelines (https://www.cdc.gov/obesity/adult/defining.html) for categorizing BMI (kg/m²), such that “Not having obesity” corresponds to a BMI <30, and “Having obesity” corresponds to a BMI ≥30.
** Hypertension status is based on mean blood pressure and self-reported use of antihypertensive medications and is defined using the 2017 Hypertension Guidelines (https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf), where “Having hypertension” is defined as mean systolic blood pressure ≥130 mmHg, mean diastolic blood pressure ≥80 mmHg, or self-reported use of antihypertensive medication. For the purpose of this analysis, participants who did not meet the 2017 Hypertension Guidelines definition for hypertension were defined as “Not having hypertension.”

Abbreviations: BMI = body mass index; NH = non-Hispanic; SE = standard error.
* Based on the F-value; post-stratified balanced repeated replication weights were used to account for the complex survey design.
^† Persons of other or multiple races not reported; percentages will not sum to 100.
^§ Obesity status is categorized based on clinical guidelines (https://www.cdc.gov/obesity/adult/defining.html) for categorizing BMI (kg/m²), such that “Not having obesity” corresponds with a BMI <30, and “Having obesity” corresponds with a BMI ≥30.
^¶ Hypertension status is based on mean blood pressure and self-reported use of antihypertensive medications and is defined using the 2017 Hypertension Guidelines (https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf), where “Having hypertension” is defined as mean systolic blood pressure ≥130 mmHg, mean diastolic blood pressure ≥80 mmHg, or self-reported use of antihypertensive medication. For the purpose of this analysis, participants who did not meet the 2017 Hypertension Guidelines definition for hypertension were defined as “Not having hypertension.”